Literature DB >> 22745046

Pharmacovigilance teaching in UK undergraduate pharmacy programmes.

Melvyn P Smith1, Sherael D Webley.   

Abstract

PURPOSE: Pharmacists in the UK are able to report spontaneous adverse drug reactions (ADRs) to the Medicines and Healthcare Products Regulatory Authority. The level of reporting by UK pharmacists remains low. This could be explained by poor knowledge of ADR reporting. The primary objective of this study was to investigate the level of pharmacovigilance education provided to pharmacy students on undergraduate pharmacy programmes in the UK.
METHODS: A cross-sectional survey was used to obtain data relating to the teaching of pharmacovigilance within schools of pharmacy. The survey was designed to reveal whether core elements pertinent to pharmacovigilance and specifically to spontaneous reporting were taught and to what extent.
RESULTS: All of the respondents taught pharmacovigilance within an assessed compulsory module. A small number (23%) did not include pharmacovigilance law within their syllabus. In 54%, the amount of time devoted to teaching pharmacy students about their role in pharmacovigilance was less than 4 h in the 4-year course; only one respondent spent approximately 20 h, the remaining respondents (38%) spent between 4 and 8 h.
CONCLUSIONS: The amount of time dedicated to the teaching of pharmacovigilance on pharmacy undergraduate degree programmes is low. Considering the importance of spontaneous reporting in drug safety and the shift in the role of the pharmacists, more time may need to be devoted to pharmacovigilance on pharmacy undergraduate courses. By doing so, new pharmacists would be more informed of the important role they play in drug safety and thereby potentially help enhance the level of ADR reporting.
Copyright © 2012 John Wiley & Sons, Ltd.

Mesh:

Year:  2012        PMID: 22745046     DOI: 10.1002/pds.3311

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  9 in total

1.  Preaching to the converted - optimising adverse drug reaction reporting by dentists.

Authors:  M M Patel; D R Radford; D Brown
Journal:  Br Dent J       Date:  2014-07       Impact factor: 1.626

Review 2.  Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?

Authors:  Paul Rutter; David Brown; Justine Howard; Christine Randall
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

3.  Adverse drug event reporting: awareness is not enough.

Authors:  Joyce A Generali
Journal:  Hosp Pharm       Date:  2014-02

4.  Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.

Authors:  Vishal R Tandon; Vivek Mahajan; Vijay Khajuria; Zahid Gillani
Journal:  Indian J Pharmacol       Date:  2015 Jan-Feb       Impact factor: 1.200

5.  Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff.

Authors:  Fabiana Rossi Varallo; Cleopatra S Planeta; Patricia de Carvalho Mastroianni
Journal:  Clinics (Sao Paulo)       Date:  2017-01-01       Impact factor: 2.365

6.  Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom.

Authors:  Ejaz Cheema; Abdul Haseeb; Tahir M Khan; Paul Sutcliffe; Donald R Singer
Journal:  Pharm Pract (Granada)       Date:  2017-08-08

7.  An evaluation of the knowledge and perceptions of pharmacy students on pharmacovigilance activities in Nigeria.

Authors:  Kanayo P Osemene; Margaret O Afolabi
Journal:  BMC Res Notes       Date:  2017-07-12

8.  Healthcare students' knowledge, attitude and perception of pharmacovigilance: A systematic review.

Authors:  Monira Alwhaibi; Noha A Al Aloola
Journal:  PLoS One       Date:  2020-05-20       Impact factor: 3.240

9.  Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists.

Authors:  Yun Mi Yu; Euni Lee; Bon Sun Koo; Kyeong Hye Jeong; Kyung Hee Choi; Lee Kyung Kang; Mo Se Lee; Kwang Hoon Choi; Jung Mi Oh; Wan Gyoon Shin
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.